These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30191007)

  • 1. Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.
    Brunt EM; Paradis V; Sempoux C; Theise ND
    Hepat Oncol; 2015 Jul; 2(3):255-273. PubMed ID: 30191007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant differentiation patterns in primary liver carcinoma.
    Sempoux C; Paradis V; Saxena R
    Semin Diagn Pathol; 2017 Mar; 34(2):176-182. PubMed ID: 28256363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and diagnostic imaging of cholangiolocellular carcinoma compared with other primary liver cancers: a surgical perspective.
    Takamura H; Gabata R; Obatake Y; Nakanuma S; Hayashi H; Kozaka K; Sasaki M; Okazaki M; Yamaguchi T; Shimbashi H; Terai S; Okamoto K; Makino I; Kinoshita J; Nakamura K; Miyashita T; Tajima H; Ninomiya I; Fushida S; Kitao A; Kitahara M; Arai K; Yamashita T; Yamashita T; Ikeda H; Satoh Y; Harada K; Kaneko S; Gabata T; Kosaka T; Ohta T
    Technol Cancer Res Treat; 2020; 19():1533033820948141. PubMed ID: 33073719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma.
    Balitzer D; Joseph NM; Ferrell L; Shafizadeh N; Jain D; Zhang X; Yeh M; di Tommaso L; Kakar S
    Mod Pathol; 2019 Oct; 32(10):1486-1494. PubMed ID: 31186529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI.
    Choi SH; Jeon SK; Lee SS; Lee JM; Hur BY; Kang HJ; Kim H; Park Y
    Eur Radiol; 2021 Dec; 31(12):9479-9488. PubMed ID: 34037829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases.
    Potretzke TA; Tan BR; Doyle MB; Brunt EM; Heiken JP; Fowler KJ
    AJR Am J Roentgenol; 2016 Jul; 207(1):25-31. PubMed ID: 26866746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hepatocellular-cholangiocarcinoma with stem cell features, cholangiolocellular subtype after inferior vena cava stent placement for a patient with Budd-Chiari syndrome.
    Sakane M; Osuga K; Matsui T; Eguchi H; Hori M; Tomiyama N
    Acta Radiol Open; 2016 Nov; 5(11):2058460116678277. PubMed ID: 27900203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined hepatocellular-cholangiocarcinoma: An update.
    Beaufrère A; Calderaro J; Paradis V
    J Hepatol; 2021 May; 74(5):1212-1224. PubMed ID: 33545267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
    Shetty AS; Fowler KJ; Brunt EM; Agarwal S; Narra VR; Menias CO
    Abdom Imaging; 2014 Apr; 39(2):310-22. PubMed ID: 24407728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas.
    Lee K; Lee KB; Jung HY; Yi NJ; Lee KW; Suh KS; Jang JJ
    BMC Cancer; 2017 Jun; 17(1):441. PubMed ID: 28645247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous Double Primary Combined Hepatocellular-cholangiocarcinoma and Cholangiolocarcinoma in a Cirrhotic Liver.
    Sakata M; Kitada K; Omote R; Sonobe H; Utsumi M; Tokunaga N; Fushimi T; Nagao R; Sakata T; Kaneyoshi T; Toyokawa T; Inagaki M
    J Clin Transl Hepatol; 2023 Aug; 11(4):991-997. PubMed ID: 37408806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A massive hepatic tumor demonstrating hepatocellular, cholangiocarcinoma and neuroendocrine lineages: A case report and review of the literature.
    Beard RE; Finkelstein SD; Borhani AA; Minervini MI; Marsh JW
    Int J Surg Case Rep; 2017; 37():26-32. PubMed ID: 28623758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma.
    Sasaki M; Sato H; Kakuda Y; Sato Y; Choi JH; Nakanuma Y
    Liver Int; 2015 Mar; 35(3):1024-35. PubMed ID: 24712771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis.
    Kim TH; Kim H; Joo I; Lee JM
    Korean J Radiol; 2020 Oct; 21(10):1115-1125. PubMed ID: 32729276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update.
    Roßner F; Sinn BV; Horst D
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling.
    Rosenberg N; Van Haele M; Lanton T; Brashi N; Bromberg Z; Adler H; Giladi H; Peled A; Goldenberg DS; Axelrod JH; Simerzin A; Chai C; Paldor M; Markezana A; Yaish D; Shemulian Z; Gross D; Barnoy S; Gefen M; Amran O; Claerhout S; Fernández-Vaquero M; García-Beccaria M; Heide D; Shoshkes-Carmel M; Schmidt Arras D; Elgavish S; Nevo Y; Benyamini H; Tirnitz-Parker JEE; Sanchez A; Herrera B; Safadi R; Kaestner KH; Rose-John S; Roskams T; Heikenwalder M; Galun E
    J Hepatol; 2022 Dec; 77(6):1631-1641. PubMed ID: 35988690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type.
    Chen J; He J; Deng M; Wu HY; Shi J; Mao L; Sun Q; Tang M; Fan XS; Qiu YD; Huang Q
    Hum Pathol; 2017 Jun; 64():118-127. PubMed ID: 28431889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.